Cell therapy refers to a therapeutic approach that aims to prevent or treat human diseases by introducing carefully chosen, expanded, and modified healthy cells into the body to replace or repair resident cell populations. Cell therapies constitute one possible clinical treatment for oncology patients, but they also hold promise in the regenerative medicine field. Depending on the intended use, cell therapies will employ genetic engineering tactics to modify the cells prior to patient transplantation. However, as with any therapeutic modality, cell therapies are highly regulated to ensure proper quality control for patient safety.

Cell Therapy Strategies

• Autologous Cell Therapy - This involves utilizing an individual's own cells or tissues, which are processed outside the body and subsequently reintroduced back into the same donor. This strategy has proven successful in clinical settings as evident by approval of CAR T cell therapies that have shown curative potential for hematologic malignancies.

• Allogeneic Cell Therapy - This uses cells from a donor to treat multiple patients. Donor cells are stored in a master cell bank (MCB) and processed for specific therapies. Allogeneic cell therapies offer the hope of an off-the-shelf solution that could be available to the masses in a short period of time.

• Xenogeneic Cell Therapy - This involves the isolation and ex vivo expansion of cells from non-human species that are intended for human transplantation. Xenogeneic cell therapies include a greater risk of cross species infection and barrier to adoption. Some barriers include rejection, genetic, anatomical and physiological mismatch. This strategy is not as prevalent as autologous or allogeneic cell therapy.

Types of Cells Used in Cell Therapy

Various types of cells can be utilized in cell therapy, including hematopoietic stem cells (HSC), skeletal muscle stem cells, mesenchymal stem cells, lymphocytes, dendritic cells and pancreatic islet cells. Hematopoietic stem cells can generate blood cells and are commonly employed in treatments such as bone marrow transplants. Skeletal muscle stem cells possess regenerative properties and can aid in the repair of damaged muscle tissues. Mesenchymal stem cells have the potential to differentiate into various cell types and exhibit immunomodulatory effects, making them suitable for treating inflammatory and autoimmune conditions. Lymphocytes, specifically T cells, and dendritic cells are vital components of the immune system and can be manipulated to enhance immune responses against cancers or infections. Pancreatic islet cells hold promise for diabetes treatment as they can replace the dysfunctional insulin-producing cells in the pancreas.

Harnessing the Power of Cell Therapy

Stem cells play a pivotal role in cellular regeneration therapy by harnessing their unique tissue repair and regeneration properties. One common approach involves using stem cells to replace damaged or dysfunctional cells in the body by directing them to differentiate into specific cell types prior to transplantation. They can be introduced into injured or diseased tissues to promote healing, making them valuable in musculoskeletal conditions or tissue damage. Certain stem cells, like mesenchymal stem cells, possess immunomodulatory properties and can be used to regulate the immune response, offering potential benefits in treating autoimmune diseases or reducing inflammation. Stem cells can also be genetically modified using techniques like CRISPR-Cas9 to correct disease-causing mutations to restore normal cellular function. Moreover, stem cells hold promise in targeting cancer cells to deliver a drug payload to limit tumor growth or kill the cancer cell altogether.

Adoptive cellular therapy is a treatment method that utilizes the body's own immune cells to target and eradicate cancer cells. This approach involves isolating immune cells, expanding their population, and potentially modifying them through genetic engineering to enhance their ability to combat cancer. Natural killer (NK) and T cells are attractive options for adoptive cell therapy approaches.

CAR T cell therapy is a type of adoptive cellular therapy that utilizes T cells to combat cancer. This involves extracting T cells from the patient’s blood and introducing a gene that codes for a receptor known as a chimeric antigen receptor (CAR). The CAR enables the modified T cells to recognize and bind to specific cancer cell antigens. After the modification, the CAR T cells are returned to the patient’s body to engage in targeted destruction of cancer cells. Currently, CAR T cell therapies have shown great success for blood born cancers but their utility for solid tumors is being tested. Applying the CAR platform to develop and clinically test CAR NK cells is ongoing and shows great promise.

Tumor-infiltrating lymphocytes (TILs) are another adoptive cell therapy strategy that shows great promise, especially for targeting solid tumors. TILs are unique because they are a native population that already recognizes cells within solid tumors and works to destroy them, unlike CAR T cells that must be engineered. However, TILs require significant expansion to generate enough cells for reinfusion. Researchers are continuing to explore way to efficiently expand TILs.

Cell Therapy Manufacturing

Cell therapy solutions encompass a range of approaches and technologies to enable safe, effective and scalable production. Closed-system processing, utilizing bioreactors and disposable systems, reduces contamination risks and simplifies the workflow. Automation and robotics streamline tasks, reducing manual errors and increasing throughput. Standardization ensures consistency and reproducibility of protocols and procedures. Rigorous quality control measures and testing ensure product safety and efficacy. Optimizing the supply chain, including timely access to raw materials and effective logistics, minimizes delays while ensuring adherence to GMP guidelines.

Cell Therapy or Gene Therapy?

Both approaches have distinct advantages and limitations depending on the specific disease and therapeutic goals. Cell therapy is suitable for conditions where tissue regeneration is necessary. However, cell therapy may require complex manufacturing processes, personalized approaches and considerations for immune compatibility. Gene therapy, on the other hand, directly targets the underlying genetic cause of disease and provides a sustained effect. Challenges such as effective gene delivery, potential immune responses and off-target effects must be addressed carefully.

Future Directions

Cell therapies continue to be a focus for the pharma and biotech industries. While T cells have been the preferred cell type, plenty of ongoing research is looking at understudied populations like macrophages. Introduction of novel cell types would expand the utility of cell therapies to address a larger patient population. The use of combinatorial treatments that include cell therapies will also continue to gain traction as synergistic effects are documented. The use of gene editing platform technologies will also continue to expand potentially decreasing development timelines and costs.

recent-articles